Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hepatic cancer
ADR ID BADD_A06705
ADR Hierarchy
09      Hepatobiliary disorders
09.04      Hepatobiliary neoplasms
09.04.02      Malignant hepatobiliary neoplasms
09.04.02.008      Hepatic cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.07      Hepatobiliary neoplasms malignant and unspecified
16.07.02      Hepatic neoplasms malignant
16.07.02.004      Hepatic cancer
Description Tumors or cancer of the LIVER. [MeSH]
MedDRA Code 10073069
MeSH ID D008113
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of liver resectable | Cancer of liver, primary | Cancer of liver, primary, non-resectable | Cancer of liver, primary, resectable | Carcinoma liver | Carcinoma liver non-resectable | Carcinoma liver resectable | Hepatic carcinoma malignant primary non-resectable | Hepatic carcinoma malignant primary resectable | Hepatic malignant neoplasm primary non-resectable | Hepatic malignant neoplasm primary resectable | Hepatic neoplasm malignant | Hepatic neoplasm malignant non-resectable | Hepatic neoplasm malignant NOS | Hepatic neoplasm malignant resectable | Hepatic tumor malignant | Liver carcinoma | Liver carcinoma non-resectable | Liver carcinoma resectable | Liver, cancer of | Liver, cancer of, non-resectable | Liver, cancer of, primary | Liver, cancer of, primary non-resectable | Liver, cancer of, primary resectable | Liver, cancer of, resectable | Malignant hepatic neoplasm | Malignant hepatic neoplasm non-resectable | Malignant hepatic neoplasm resectable | Malignant liver tumor | Malignant liver tumor non-resectable | Malignant liver tumor resectable | Malignant liver tumour | Malignant liver tumour non-resectable | Malignant liver tumour resectable | Malignant neoplasm of liver, not specified as primary or secondary | Malignant neoplasm of liver, primary | Malignant neoplasm of liver, primary non-resectable | Malignant neoplasm of liver, primary resectable | Primary cancer of liver | Primary cancer of liver non-resectable | Primary cancer of liver resectable | Primary liver cancer non-resectable | Primary liver cancer resectable | Primary malignant neoplasm of liver | Carcinoma of liver | Hepatic adenocarcinoma | Liver adenocarcinoma | Squamous cell carcinoma of liver | Hepatic cancer | Hepatic tumour malignant | Anaplastic carcinoma of liver | Liver Neoplasms | Neoplasms, Hepatic | Neoplasms, Liver | Liver Neoplasm | Neoplasm, Liver | Hepatic Neoplasms | Hepatic Neoplasm | Neoplasm, Hepatic | Cancer of Liver | Hepatocellular Cancer | Cancers, Hepatocellular | Hepatocellular Cancers | Hepatic Cancer | Cancer, Hepatic | Cancers, Hepatic | Hepatic Cancers | Liver Cancer | Cancer, Liver | Cancers, Liver | Liver Cancers | Cancer of the Liver | Cancer, Hepatocellular
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01250Lasofoxifene--
BADD_D01257Letrozole--
BADD_D01260Leuprolide acetate0.003585%
BADD_D01318Lorazepam--
BADD_D01325Lovastatin--
BADD_D01348Mangafodipir trisodium--
BADD_D01401Metformin--
BADD_D01572Nitisinone0.010781%
BADD_D01592Obeticholic acid0.001564%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01824Pravastatin--
BADD_D01835Pregabalin--
BADD_D01858Propagermanium--
BADD_D01898Rabeprazole--
BADD_D01906Raltegravir potassium--
BADD_D01913Ranitidine0.011881%
BADD_D01922Regorafenib0.000638%
BADD_D01933Ribavirin0.045492%
BADD_D01938Rifaximin0.000965%
BADD_D01954Rivaroxaban--
BADD_D01955Rivastigmine--
BADD_D02026Simvastatin--
BADD_D02029Sitagliptin0.000080%
BADD_D02053Sofosbuvir0.004798%
BADD_D02058Sorafenib0.005843%
BADD_D02147Telmisartan0.000260%
BADD_D02154Tenofovir0.029081%
BADD_D02170Testosterone--
BADD_D02230Tizanidine--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages